Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved Oncologic Outcomes with Trimodality Therapy for Radiation-Associated Angiosarcoma of the Breast.

Annals of surgical oncology·2026
Same author

Pregnancy-associated progression with spontaneous postpartum regression in metastatic alveolar soft part sarcoma.

BMJ case reports·2026
Same author

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

Nature medicine·2026
Same author

A Multicenter Retrospective Outcomes Analysis of Patients with Localized Synovial Sarcoma.

Cancer research communications·2026
Same author

Preoperative (Neoadjuvant) Combined Chemoradiotherapy in the Management of Localized Soft Tissue Sarcoma: A Retrospective Study.

Cancers·2026
Same author

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Aug 3, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to

Natalie K Heater1, Scott Okuno2, Steven Robinson2

  • 1Department of Medicine, Northwestern University, Chicago, IL 60611, USA.

Journal of Clinical Medicine
|April 13, 2023
PubMed
Summary

Treating rare soft tissue sarcoma requires collaboration. The Midwest Sarcoma Trials Partnership (MWSTP) created a network to improve clinical trials and proposes online platforms to expand expert treatment reach.

Keywords:
Midwest Sarcoma Trials Partnershipadvanced soft tissue sarcomacollaborationmultidisciplinary tumor boardsarcoma treatmenttargeted therapy

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

Related Experiment Videos

Last Updated: Aug 3, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

Area of Science:

  • Oncology
  • Clinical Trials
  • Medical Networks

Background:

  • Sarcoma treatment is complex, requiring multidisciplinary specialist teams for surgical, radiation, and medical management.
  • Advanced or nonresectable soft tissue sarcoma treatment guidelines have evolved with new immunotherapies and targeted therapies.
  • Institutional collaboration is crucial for enhancing clinical trial accrual in rare cancers.

Purpose of the Study:

  • To describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in establishing a collaborative network.
  • To propose a novel model using online platforms to broaden access to specialized expertise for advanced soft tissue sarcoma treatment.

Main Methods:

  • Establishment of the Midwest Sarcoma Trials Partnership (MWSTP) connecting academic centers and community sites.
  • Description of a proposed model leveraging online platforms to extend clinical expertise.

Main Results:

  • The MWSTP successfully created a network of academic and community sites.
  • A new model utilizing online platforms is proposed to expand the reach of clinical expertise.

Conclusions:

  • Collaborative networks like MWSTP are vital for advancing sarcoma research and treatment.
  • Online platforms offer a promising avenue to democratize access to specialized sarcoma care.